{"id":3291,"date":"2025-11-14T11:26:32","date_gmt":"2025-11-14T10:26:32","guid":{"rendered":"https:\/\/biotechaustria.org\/mitarbeiter\/guido-gualdoni\/"},"modified":"2026-03-16T08:44:44","modified_gmt":"2026-03-16T07:44:44","slug":"guido-gualdoni","status":"publish","type":"mitarbeiter","link":"https:\/\/biotechaustria.org\/en\/mitarbeiter\/guido-gualdoni\/","title":{"rendered":"GUIDO GUALDONI"},"content":{"rendered":"<p>Dr. Dr. Guido Gualdoni is the founder and CEO of G.ST Antivirals GmbH, a biopharmaceutical company developing antiviral therapeutics. He has led the company from an academic spin-off to Phase 2 clinical trials and secured over \u20ac10 million in funding. With several years of experience in internal medicine and his habilitation in immunology, he combines scientific expertise with entrepreneurial experience.<\/p>\n","protected":false},"featured_media":2911,"parent":0,"template":"","kategorie_mitarbeiter":[43],"class_list":["post-3291","mitarbeiter","type-mitarbeiter","status-publish","has-post-thumbnail","hentry","kategorie_mitarbeiter-vorstand"],"acf":[],"_links":{"self":[{"href":"https:\/\/biotechaustria.org\/en\/wp-json\/wp\/v2\/mitarbeiter\/3291","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/biotechaustria.org\/en\/wp-json\/wp\/v2\/mitarbeiter"}],"about":[{"href":"https:\/\/biotechaustria.org\/en\/wp-json\/wp\/v2\/types\/mitarbeiter"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/biotechaustria.org\/en\/wp-json\/wp\/v2\/media\/2911"}],"wp:attachment":[{"href":"https:\/\/biotechaustria.org\/en\/wp-json\/wp\/v2\/media?parent=3291"}],"wp:term":[{"taxonomy":"kategorie_mitarbeiter","embeddable":true,"href":"https:\/\/biotechaustria.org\/en\/wp-json\/wp\/v2\/kategorie_mitarbeiter?post=3291"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}